The frequency of clinically important valve regurgitation was significantly increased in patients taking pergolide or cabergoline, but not in patients taking non?ergot-derived dopamine agonists, as compared with control subjects.
英
美
- 與對照組相比，服用培高利特或者卡麥角林的患者臨床上發(fā)生重要瓣膜返流的頻率顯著(zhù)增加，但服用非麥角??生的多巴胺受體激動(dòng)劑的患者瓣膜返流的發(fā)生率卻未增加。
